Some uptake differences were noted between distinct tumors, with ccRCC cases showing the highest uptake and benign oncocytoma showing lower uptake, suggesting that FAP expression may be heterogeneous across renal tumors. The gene discussed is FAP; the disease is oncocytic neoplasm.